secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001683168-25-000077
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals sold 17.5M shares via ATM; shares outstanding now 74.96M
----------------------------------------------------------------------------

- Sold 17,475,827 shares under at-the-market agreement since last 10-Q (Sept 30, 2024).
- As of Jan 3, 2025, common shares outstanding increased to 74,962,533 from ~57.5M.
- No disclosure of pricing or use of proceeds; significant dilution (~30%) for existing holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825000077/0001683168-25-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825000077/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer